about
Endoscopic ultrasound versus magnetic resonance cholangiopancreatography for common bile duct stonesUltrasound versus liver function tests for diagnosis of common bile duct stonesEndoscopic retrograde cholangiopancreatography versus intraoperative cholangiography for diagnosis of common bile duct stonesTests for diagnosis of common bile duct stonesCirrhosis and autoimmune liver disease: Current understandingRegulators of Cholangiocyte Proliferation.Characterization of animal models for primary sclerosing cholangitis (PSC).Na(+) /H(+) exchanger regulatory factor 1 knockout mice have an attenuated hepatic inflammatory response and are protected from cholestatic liver injuryEffects of Melittin Treatment in Cholangitis and Biliary Fibrosis in a Model of Xenobiotic-Induced Cholestasis in MiceCell signals influencing hepatic fibrosisDetection of Autoantibodies to Vascular Endothelial Growth Factor Receptor-3 in Bile Duct Ligated Rats and Correlations with a Panel of Traditional Markers of Liver Diseases.Xenobiotic-induced liver injury and fibrosis.The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice.Anti-fibrotic effects of fresh and cryopreserved human amniotic membrane in a rat liver fibrosis model.Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2(-/-) mice.Can a fibrotic liver afford epithelial-mesenchymal transition?From pathogenesis to novel therapies in the treatment of primary biliary cholangitis.Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient KitW-sh mice.Vitamin D and the Liver-Correlation or Cause?CD8 T cells primed in the gut-associated lymphoid tissue induce immune-mediated cholangitis in mice.The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats.
P2860
Q24187882-7B6FD18C-A0B4-4C8D-91BC-62C6A5F09337Q24187889-7326854B-902C-45AB-94FC-30E7387478A6Q24187893-4A13A8A0-223F-4EF4-8DFB-1F5BB123442EQ24201846-90F37F67-7E11-4728-9FB3-37C2B76A9726Q28070154-4733828C-861C-411A-90AB-F4D238ED5264Q33863341-683C679A-2C0B-456B-A0CA-1B5562ECE054Q35896870-4338A07C-52D0-4846-B537-42D0D35EE6C9Q36108916-BF149CE3-49ED-4B6C-9D75-B62F355EFB4DQ36115194-1857469E-3375-4A43-B2BB-6D080D0C4513Q36220879-73304925-35D6-401D-A65E-FD47AD01172DQ36880742-B5F58E5B-9744-44DA-8738-1CBFF2BB179FQ37997455-BEF96570-A74C-44E8-A27C-A7AF598E24DFQ38775284-F4DC9A21-3883-4B57-B350-52809C75DA32Q40059303-0B3FD805-AB15-4510-B888-AD28405ED482Q41643115-A56131BA-A559-409F-9470-463EAE5F80E5Q42334109-8BAA1340-1A02-4B8A-B936-665F59384B7CQ46135644-2437C80A-65E8-49DA-8A9A-D5D5174D741FQ47986302-A254EF57-BA2E-4BDE-9E84-BA92CFB0A343Q52586105-015958B0-A8C0-4F7C-B9D1-914B3E4111A8Q52882494-AC7414E6-52A3-4405-8F8E-A24E4ED584BCQ55340936-39D242E5-67FD-4A28-8652-5611E6B9FA9C
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Fibrosis in autoimmune and cholestatic liver disease
@ast
Fibrosis in autoimmune and cholestatic liver disease
@en
type
label
Fibrosis in autoimmune and cholestatic liver disease
@ast
Fibrosis in autoimmune and cholestatic liver disease
@en
prefLabel
Fibrosis in autoimmune and cholestatic liver disease
@ast
Fibrosis in autoimmune and cholestatic liver disease
@en
P2093
P2860
P921
P1476
Fibrosis in autoimmune and cholestatic liver disease
@en
P2093
Christoph H Österreicher
Melitta Penz-Österreicher
Michael Trauner
P2860
P304
P356
10.1016/J.BPG.2011.02.001
P5008
P577
2011-04-01T00:00:00Z